More than 2 years after inking a $22 million deal to settle charges that it violated the Foreign Corrupt Practices Act, Biomet says the SEC issued a subpoena over alleged “improprieties” in Brazil and Mexico.
Biomet said last week that the U.S. Securities & Exchange Commission issued a subpoena over alleged “improprieties” by Biomet employees in Brazil and Mexico, more than 2 years after the medical device company settled similar allegations with the SEC and the U.S. Justice Dept. for more than $22 million.
Help employers find you! Check out all the jobs and post your resume.
